Abstract
Mutations in B4GALNT1 are involved in hereditary spastic paraplegia subtype 26 (SPG26) in an autosomal recessive manner. The clinical symptoms of SPG26 caused by B4GALNT1 mutations include lower extremity spasticity, muscle weakness, and gait abnormality. Here, we report the clinical features of an autosomal recessive CMT patient with a novel compound heterozygous B4GALNT1 mutation. To identify the causative factors and characterize the clinical features of a Korean family with motor and sensory neuropathies, a whole exome sequencing (WES) was performed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.